nodes	percent_of_prediction	percent_of_DWPC	metapath
Loperamide—CYP2D6—schizophrenia	0.299	0.583	CbGaD
Loperamide—ABCB1—schizophrenia	0.214	0.417	CbGaD
Loperamide—POMC—locus ceruleus—schizophrenia	0.0242	0.126	CbGeAlD
Loperamide—CACNA1A—cerebellar cortex—schizophrenia	0.0189	0.0984	CbGeAlD
Loperamide—POMC—autonomic nervous system—schizophrenia	0.0129	0.0672	CbGeAlD
Loperamide—POMC—telencephalic ventricle—schizophrenia	0.0115	0.06	CbGeAlD
Loperamide—POMC—urine—schizophrenia	0.0105	0.0548	CbGeAlD
Loperamide—POMC—blood plasma—schizophrenia	0.00548	0.0286	CbGeAlD
Loperamide—OPRM1—telencephalic ventricle—schizophrenia	0.00432	0.0226	CbGeAlD
Loperamide—CALM2—pons—schizophrenia	0.00381	0.0199	CbGeAlD
Loperamide—CALM1—pons—schizophrenia	0.0038	0.0198	CbGeAlD
Loperamide—CALM1—autonomic nervous system—schizophrenia	0.0035	0.0183	CbGeAlD
Loperamide—CALM2—ear—schizophrenia	0.00314	0.0164	CbGeAlD
Loperamide—CALM1—ear—schizophrenia	0.00313	0.0163	CbGeAlD
Loperamide—POMC—forebrain—schizophrenia	0.003	0.0157	CbGeAlD
Loperamide—CACNA1A—forebrain—schizophrenia	0.00286	0.015	CbGeAlD
Loperamide—POMC—telencephalon—schizophrenia	0.00276	0.0144	CbGeAlD
Loperamide—CALM2—pineal body—schizophrenia	0.00272	0.0142	CbGeAlD
Loperamide—CALM1—pineal body—schizophrenia	0.00271	0.0141	CbGeAlD
Loperamide—CACNA1A—telencephalon—schizophrenia	0.00263	0.0137	CbGeAlD
Loperamide—POMC—gonad—schizophrenia	0.0023	0.012	CbGeAlD
Loperamide—POMC—blood—schizophrenia	0.00201	0.0105	CbGeAlD
Loperamide—POMC—midbrain—schizophrenia	0.00198	0.0103	CbGeAlD
Loperamide—POMC—endocrine gland—schizophrenia	0.00174	0.00908	CbGeAlD
Loperamide—OPRD1—forebrain—schizophrenia	0.00166	0.00864	CbGeAlD
Loperamide—POMC—nervous system—schizophrenia	0.00163	0.0085	CbGeAlD
Loperamide—CYP3A4—urine—schizophrenia	0.00161	0.0084	CbGeAlD
Loperamide—OPRK1—forebrain—schizophrenia	0.00159	0.00829	CbGeAlD
Loperamide—CYP2D6—urine—schizophrenia	0.00158	0.00827	CbGeAlD
Loperamide—POMC—central nervous system—schizophrenia	0.00157	0.00819	CbGeAlD
Loperamide—CACNA1A—nervous system—schizophrenia	0.00155	0.00812	CbGeAlD
Loperamide—POMC—cerebellum—schizophrenia	0.00153	0.008	CbGeAlD
Loperamide—OPRD1—telencephalon—schizophrenia	0.00152	0.00795	CbGeAlD
Loperamide—CACNA1A—central nervous system—schizophrenia	0.0015	0.00782	CbGeAlD
Loperamide—CALM2—blood plasma—schizophrenia	0.0015	0.00781	CbGeAlD
Loperamide—CALM1—blood plasma—schizophrenia	0.00149	0.00777	CbGeAlD
Loperamide—CACNA1A—cerebellum—schizophrenia	0.00146	0.00764	CbGeAlD
Loperamide—POMC—brain—schizophrenia	0.00124	0.0065	CbGeAlD
Loperamide—CYP2C8—blood plasma—schizophrenia	0.00124	0.00647	CbGeAlD
Loperamide—CACNA1A—brain—schizophrenia	0.00119	0.0062	CbGeAlD
Loperamide—OPRM1—forebrain—schizophrenia	0.00113	0.00589	CbGeAlD
Loperamide—CYP2B6—blood plasma—schizophrenia	0.00111	0.00581	CbGeAlD
Loperamide—OPRM1—telencephalon—schizophrenia	0.00104	0.00542	CbGeAlD
Loperamide—CALM3—telencephalon—schizophrenia	0.000959	0.00501	CbGeAlD
Loperamide—OPRD1—nervous system—schizophrenia	0.000899	0.00469	CbGeAlD
Loperamide—OPRD1—central nervous system—schizophrenia	0.000865	0.00452	CbGeAlD
Loperamide—OPRK1—nervous system—schizophrenia	0.000861	0.0045	CbGeAlD
Loperamide—CYP3A4—blood plasma—schizophrenia	0.00084	0.00438	CbGeAlD
Loperamide—OPRK1—central nervous system—schizophrenia	0.000829	0.00433	CbGeAlD
Loperamide—CYP2D6—blood plasma—schizophrenia	0.000826	0.00431	CbGeAlD
Loperamide—CALM2—forebrain—schizophrenia	0.000819	0.00428	CbGeAlD
Loperamide—CALM1—forebrain—schizophrenia	0.000815	0.00426	CbGeAlD
Loperamide—OPRK1—cerebellum—schizophrenia	0.000811	0.00423	CbGeAlD
Loperamide—OPRM1—blood—schizophrenia	0.000755	0.00394	CbGeAlD
Loperamide—CALM2—telencephalon—schizophrenia	0.000753	0.00393	CbGeAlD
Loperamide—CALM1—telencephalon—schizophrenia	0.00075	0.00392	CbGeAlD
Loperamide—OPRM1—midbrain—schizophrenia	0.000745	0.00389	CbGeAlD
Loperamide—Buclizine—CHRM1—schizophrenia	0.000733	0.0778	CrCbGaD
Loperamide—CALM3—blood—schizophrenia	0.000698	0.00364	CbGeAlD
Loperamide—CALM3—midbrain—schizophrenia	0.000689	0.0036	CbGeAlD
Loperamide—OPRD1—brain—schizophrenia	0.000687	0.00359	CbGeAlD
Loperamide—Clidinium—CHRM1—schizophrenia	0.000671	0.0711	CrCbGaD
Loperamide—OPRK1—brain—schizophrenia	0.000658	0.00344	CbGeAlD
Loperamide—OPRM1—endocrine gland—schizophrenia	0.000655	0.00342	CbGeAlD
Loperamide—CALM2—gonad—schizophrenia	0.000629	0.00328	CbGeAlD
Loperamide—CALM1—gonad—schizophrenia	0.000626	0.00327	CbGeAlD
Loperamide—OPRM1—nervous system—schizophrenia	0.000613	0.0032	CbGeAlD
Loperamide—Levomethadyl Acetate—CHRNA3—schizophrenia	0.000598	0.0634	CrCbGaD
Loperamide—ABCB1—blood plasma—schizophrenia	0.000594	0.0031	CbGeAlD
Loperamide—OPRM1—central nervous system—schizophrenia	0.00059	0.00308	CbGeAlD
Loperamide—Isopropamide—CHRM1—schizophrenia	0.00057	0.0605	CrCbGaD
Loperamide—CALM2—blood—schizophrenia	0.000548	0.00286	CbGeAlD
Loperamide—CALM1—blood—schizophrenia	0.000545	0.00285	CbGeAlD
Loperamide—CALM2—midbrain—schizophrenia	0.000541	0.00282	CbGeAlD
Loperamide—Mepenzolate—CHRM1—schizophrenia	0.000539	0.0572	CrCbGaD
Loperamide—CALM1—midbrain—schizophrenia	0.000538	0.00281	CbGeAlD
Loperamide—CALM3—cerebellum—schizophrenia	0.000533	0.00278	CbGeAlD
Loperamide—Haloperidol—GRIN2B—schizophrenia	0.000477	0.0506	CrCbGaD
Loperamide—CALM2—endocrine gland—schizophrenia	0.000475	0.00248	CbGeAlD
Loperamide—CALM1—endocrine gland—schizophrenia	0.000473	0.00247	CbGeAlD
Loperamide—Diphenidol—CHRM1—schizophrenia	0.000472	0.0501	CrCbGaD
Loperamide—Darifenacin—CHRM1—schizophrenia	0.000469	0.0497	CrCbGaD
Loperamide—OPRM1—brain—schizophrenia	0.000468	0.00245	CbGeAlD
Loperamide—CYP2B6—gonad—schizophrenia	0.000467	0.00244	CbGeAlD
Loperamide—CYP2C8—blood—schizophrenia	0.000454	0.00237	CbGeAlD
Loperamide—CYP2D6—forebrain—schizophrenia	0.000453	0.00236	CbGeAlD
Loperamide—CALM2—nervous system—schizophrenia	0.000445	0.00232	CbGeAlD
Loperamide—CALM1—nervous system—schizophrenia	0.000443	0.00231	CbGeAlD
Loperamide—CALM3—brain—schizophrenia	0.000433	0.00226	CbGeAlD
Loperamide—CALM2—central nervous system—schizophrenia	0.000428	0.00224	CbGeAlD
Loperamide—CALM1—central nervous system—schizophrenia	0.000426	0.00223	CbGeAlD
Loperamide—CALM2—cerebellum—schizophrenia	0.000419	0.00219	CbGeAlD
Loperamide—CALM1—cerebellum—schizophrenia	0.000417	0.00218	CbGeAlD
Loperamide—CYP2D6—telencephalon—schizophrenia	0.000416	0.00217	CbGeAlD
Loperamide—CYP2B6—blood—schizophrenia	0.000407	0.00213	CbGeAlD
Loperamide—CYP2C8—endocrine gland—schizophrenia	0.000394	0.00206	CbGeAlD
Loperamide—CYP2B6—endocrine gland—schizophrenia	0.000353	0.00184	CbGeAlD
Loperamide—CALM2—brain—schizophrenia	0.00034	0.00178	CbGeAlD
Loperamide—Meclizine—CYP1A2—schizophrenia	0.000339	0.0359	CrCbGaD
Loperamide—CALM1—brain—schizophrenia	0.000338	0.00177	CbGeAlD
Loperamide—CYP2B6—nervous system—schizophrenia	0.000331	0.00173	CbGeAlD
Loperamide—Toremifene—ESR1—schizophrenia	0.000328	0.0347	CrCbGaD
Loperamide—ABCB1—forebrain—schizophrenia	0.000326	0.0017	CbGeAlD
Loperamide—CYP2B6—central nervous system—schizophrenia	0.000318	0.00166	CbGeAlD
Loperamide—CYP3A4—blood—schizophrenia	0.000308	0.00161	CbGeAlD
Loperamide—CYP2D6—blood—schizophrenia	0.000303	0.00158	CbGeAlD
Loperamide—ABCB1—telencephalon—schizophrenia	0.000299	0.00156	CbGeAlD
Loperamide—CYP2C8—brain—schizophrenia	0.000282	0.00147	CbGeAlD
Loperamide—Haloperidol—DRD4—schizophrenia	0.000281	0.0298	CrCbGaD
Loperamide—Methadone—HTR3A—schizophrenia	0.000277	0.0294	CrCbGaD
Loperamide—CYP3A4—endocrine gland—schizophrenia	0.000267	0.00139	CbGeAlD
Loperamide—CYP2D6—endocrine gland—schizophrenia	0.000262	0.00137	CbGeAlD
Loperamide—CYP2B6—brain—schizophrenia	0.000253	0.00132	CbGeAlD
Loperamide—Toremifene—CYP1A2—schizophrenia	0.000252	0.0268	CrCbGaD
Loperamide—ABCB1—gonad—schizophrenia	0.00025	0.0013	CbGeAlD
Loperamide—CYP3A4—nervous system—schizophrenia	0.00025	0.0013	CbGeAlD
Loperamide—Haloperidol—HTR1B—schizophrenia	0.00025	0.0265	CrCbGaD
Loperamide—Clemastine—CYP2D6—schizophrenia	0.000246	0.0261	CrCbGaD
Loperamide—CYP2D6—nervous system—schizophrenia	0.000246	0.00128	CbGeAlD
Loperamide—Haloperidol—DRD3—schizophrenia	0.000242	0.0257	CrCbGaD
Loperamide—CYP3A4—central nervous system—schizophrenia	0.00024	0.00126	CbGeAlD
Loperamide—Haloperidol—DRD1—schizophrenia	0.000238	0.0252	CrCbGaD
Loperamide—CYP2D6—central nervous system—schizophrenia	0.000237	0.00124	CbGeAlD
Loperamide—CYP2D6—cerebellum—schizophrenia	0.000231	0.00121	CbGeAlD
Loperamide—ABCB1—blood—schizophrenia	0.000218	0.00114	CbGeAlD
Loperamide—ABCB1—midbrain—schizophrenia	0.000215	0.00112	CbGeAlD
Loperamide—ABCB1—endocrine gland—schizophrenia	0.000189	0.000986	CbGeAlD
Loperamide—CYP2D6—brain—schizophrenia	0.000188	0.000981	CbGeAlD
Loperamide—ABCB1—nervous system—schizophrenia	0.000177	0.000923	CbGeAlD
Loperamide—Darifenacin—CYP2D6—schizophrenia	0.000175	0.0186	CrCbGaD
Loperamide—Clotrimazole—CYP1A2—schizophrenia	0.000171	0.0181	CrCbGaD
Loperamide—Fexofenadine—CYP2D6—schizophrenia	0.00017	0.0181	CrCbGaD
Loperamide—ABCB1—central nervous system—schizophrenia	0.00017	0.000888	CbGeAlD
Loperamide—Haloperidol—DRD2—schizophrenia	0.000168	0.0178	CrCbGaD
Loperamide—ABCB1—cerebellum—schizophrenia	0.000166	0.000868	CbGeAlD
Loperamide—Haloperidol—CYP1A2—schizophrenia	0.000154	0.0163	CrCbGaD
Loperamide—Toremifene—ABCB1—schizophrenia	0.000139	0.0148	CrCbGaD
Loperamide—ABCB1—brain—schizophrenia	0.000135	0.000705	CbGeAlD
Loperamide—Clotrimazole—CYP2D6—schizophrenia	0.000132	0.014	CrCbGaD
Loperamide—Tamoxifen—ESR1—schizophrenia	0.000131	0.0139	CrCbGaD
Loperamide—Haloperidol—HTR2A—schizophrenia	0.00013	0.0137	CrCbGaD
Loperamide—Fexofenadine—ABCB1—schizophrenia	0.000122	0.0129	CrCbGaD
Loperamide—Haloperidol—CYP2D6—schizophrenia	0.000119	0.0126	CrCbGaD
Loperamide—Dextropropoxyphene—CYP2D6—schizophrenia	0.000114	0.0121	CrCbGaD
Loperamide—Tamoxifen—CYP1A2—schizophrenia	0.000101	0.0107	CrCbGaD
Loperamide—Methadone—CYP1A2—schizophrenia	0.0001	0.0106	CrCbGaD
Loperamide—Clotrimazole—ABCB1—schizophrenia	9.4e-05	0.00997	CrCbGaD
Loperamide—Haloperidol—ABCB1—schizophrenia	8.46e-05	0.00898	CrCbGaD
Loperamide—Fentanyl—ABCB1—schizophrenia	8.03e-05	0.00852	CrCbGaD
Loperamide—Tamoxifen—CYP2D6—schizophrenia	7.78e-05	0.00825	CrCbGaD
Loperamide—Methadone—CYP2D6—schizophrenia	7.72e-05	0.00819	CrCbGaD
Loperamide—Tamoxifen—ABCB1—schizophrenia	5.56e-05	0.00589	CrCbGaD
Loperamide—Methadone—ABCB1—schizophrenia	5.51e-05	0.00584	CrCbGaD
Loperamide—CALM2—Hemostasis—EP300—schizophrenia	7.16e-06	2.5e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—TH—schizophrenia	7.16e-06	2.5e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—GSTP1—schizophrenia	7.16e-06	2.5e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—MAOA—schizophrenia	7.14e-06	2.49e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GCLM—schizophrenia	7.12e-06	2.48e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—TPH1—schizophrenia	7.12e-06	2.48e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—APOE—schizophrenia	7.11e-06	2.48e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling by NGF—AKT1—schizophrenia	7.06e-06	2.47e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—APOA1—schizophrenia	7.03e-06	2.46e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—ERBB3—schizophrenia	7.03e-06	2.45e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—DRD4—schizophrenia	7.02e-06	2.45e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—DRD4—schizophrenia	7.02e-06	2.45e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—SNAP25—schizophrenia	7e-06	2.44e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—CYP2D6—schizophrenia	7e-06	2.44e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—COMT—schizophrenia	7e-06	2.44e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—GSTP1—schizophrenia	6.97e-06	2.43e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—YWHAZ—schizophrenia	6.95e-06	2.43e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—YWHAZ—schizophrenia	6.95e-06	2.43e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—MAOA—schizophrenia	6.95e-06	2.43e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CNR1—schizophrenia	6.93e-06	2.42e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling by NGF—AKT1—schizophrenia	6.83e-06	2.38e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling by NGF—AKT1—schizophrenia	6.83e-06	2.38e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—ERBB3—schizophrenia	6.8e-06	2.37e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—ERBB3—schizophrenia	6.8e-06	2.37e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—ESR1—schizophrenia	6.79e-06	2.37e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—ABCB1—schizophrenia	6.78e-06	2.37e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—COMT—schizophrenia	6.77e-06	2.36e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—COMT—schizophrenia	6.77e-06	2.36e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—DRD2—schizophrenia	6.76e-06	2.36e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—HTR7—schizophrenia	6.76e-06	2.36e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—MTHFR—schizophrenia	6.76e-06	2.36e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—GSTP1—schizophrenia	6.74e-06	2.35e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—GSTP1—schizophrenia	6.74e-06	2.35e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—MAOA—schizophrenia	6.72e-06	2.35e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—MAOA—schizophrenia	6.72e-06	2.35e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CNR1—schizophrenia	6.71e-06	2.34e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CNR1—schizophrenia	6.71e-06	2.34e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PRKD1—schizophrenia	6.69e-06	2.34e-05	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—EP300—schizophrenia	6.66e-06	2.33e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—SNAP25—schizophrenia	6.6e-06	2.3e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—ABCB1—schizophrenia	6.59e-06	2.3e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—PLA2G4A—schizophrenia	6.58e-06	2.3e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—GSTM1—schizophrenia	6.58e-06	2.3e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—DRD2—schizophrenia	6.54e-06	2.28e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—HTR7—schizophrenia	6.54e-06	2.28e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—DRD2—schizophrenia	6.54e-06	2.28e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—HTR7—schizophrenia	6.54e-06	2.28e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—MTHFR—schizophrenia	6.53e-06	2.28e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—MTHFR—schizophrenia	6.53e-06	2.28e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling by Wnt—AKT1—schizophrenia	6.5e-06	2.27e-05	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—EP300—schizophrenia	6.45e-06	2.25e-05	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—EP300—schizophrenia	6.45e-06	2.25e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—PLA2G4A—schizophrenia	6.4e-06	2.23e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—GSTM1—schizophrenia	6.4e-06	2.23e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—PRL—schizophrenia	6.39e-06	2.23e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—ABCB1—schizophrenia	6.38e-06	2.23e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—ABCB1—schizophrenia	6.38e-06	2.23e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—CYP1A2—schizophrenia	6.33e-06	2.21e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling by Wnt—AKT1—schizophrenia	6.29e-06	2.2e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling by Wnt—AKT1—schizophrenia	6.29e-06	2.2e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—APOE—schizophrenia	6.29e-06	2.2e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—TH—schizophrenia	6.24e-06	2.18e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—APOA1—schizophrenia	6.22e-06	2.17e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—PLA2G4A—schizophrenia	6.19e-06	2.16e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—PLA2G4A—schizophrenia	6.19e-06	2.16e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—GSTM1—schizophrenia	6.19e-06	2.16e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—GSTM1—schizophrenia	6.19e-06	2.16e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—PRL—schizophrenia	6.18e-06	2.16e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—PRL—schizophrenia	6.18e-06	2.16e-05	CbGpPWpGaD
Loperamide—OPRD1—GPCR downstream signaling—AKT1—schizophrenia	6.16e-06	2.15e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—GSK3B—schizophrenia	6.16e-06	2.15e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—COMT—schizophrenia	6.09e-06	2.13e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—APOE—schizophrenia	6.08e-06	2.12e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—APOE—schizophrenia	6.08e-06	2.12e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—GSTP1—schizophrenia	6.06e-06	2.12e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—MAOA—schizophrenia	6.05e-06	2.11e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—APOA1—schizophrenia	6.01e-06	2.1e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—APOA1—schizophrenia	6.01e-06	2.1e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—CYP1A2—schizophrenia	5.96e-06	2.08e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—S100B—schizophrenia	5.95e-06	2.08e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—GSK3B—schizophrenia	5.9e-06	2.06e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—TH—schizophrenia	5.88e-06	2.05e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism of lipids and lipoproteins—EP300—schizophrenia	5.86e-06	2.05e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—FOS—schizophrenia	5.86e-06	2.05e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—MTHFR—schizophrenia	5.81e-06	2.03e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—S100B—schizophrenia	5.76e-06	2.01e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—S100B—schizophrenia	5.76e-06	2.01e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—ABCB1—schizophrenia	5.74e-06	2e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—GSK3B—schizophrenia	5.71e-06	1.99e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—GSK3B—schizophrenia	5.71e-06	1.99e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—ERBB4—schizophrenia	5.69e-06	1.99e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—FOS—schizophrenia	5.67e-06	1.98e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—FOS—schizophrenia	5.67e-06	1.98e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—MTHFR—schizophrenia	5.66e-06	1.98e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—AKT1—schizophrenia	5.6e-06	1.95e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GAPDH—schizophrenia	5.58e-06	1.95e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—GSTM1—schizophrenia	5.57e-06	1.94e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—PLA2G4A—schizophrenia	5.57e-06	1.94e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CLOCK—schizophrenia	5.53e-06	1.93e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—ERBB4—schizophrenia	5.51e-06	1.92e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—ERBB4—schizophrenia	5.51e-06	1.92e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—MTHFR—schizophrenia	5.47e-06	1.91e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—MTHFR—schizophrenia	5.47e-06	1.91e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—EP300—schizophrenia	5.47e-06	1.91e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—GSK3B—schizophrenia	5.45e-06	1.9e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—APOE—schizophrenia	5.41e-06	1.89e-05	CbGpPWpGaD
Loperamide—OPRK1—GPCR downstream signaling—AKT1—schizophrenia	5.4e-06	1.89e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—TPH2—schizophrenia	5.39e-06	1.88e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CACNB2—schizophrenia	5.39e-06	1.88e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—PLA2G4A—schizophrenia	5.35e-06	1.87e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—APOA1—schizophrenia	5.35e-06	1.87e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—DPYD—schizophrenia	5.31e-06	1.85e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—COMT—schizophrenia	5.3e-06	1.85e-05	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—TP53—schizophrenia	5.3e-06	1.85e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—GSTP1—schizophrenia	5.28e-06	1.84e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—GSK3B—schizophrenia	5.27e-06	1.84e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—GSK3B—schizophrenia	5.27e-06	1.84e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—MAOA—schizophrenia	5.27e-06	1.84e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—APOE—schizophrenia	5.27e-06	1.84e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—NRG1—schizophrenia	5.25e-06	1.83e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MEF2C—schizophrenia	5.21e-06	1.82e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—APOA1—schizophrenia	5.21e-06	1.82e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—PLA2G4A—schizophrenia	5.18e-06	1.81e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—PLA2G4A—schizophrenia	5.18e-06	1.81e-05	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—TP53—schizophrenia	5.12e-06	1.79e-05	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—TP53—schizophrenia	5.12e-06	1.79e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—APOE—schizophrenia	5.09e-06	1.78e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—APOE—schizophrenia	5.09e-06	1.78e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—NRG1—schizophrenia	5.08e-06	1.77e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—NRG1—schizophrenia	5.08e-06	1.77e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MEF2C—schizophrenia	5.04e-06	1.76e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MEF2C—schizophrenia	5.04e-06	1.76e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—APOA1—schizophrenia	5.04e-06	1.76e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—APOA1—schizophrenia	5.04e-06	1.76e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—YWHAZ—schizophrenia	5.03e-06	1.76e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—COMT—schizophrenia	5e-06	1.75e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—GSTP1—schizophrenia	4.97e-06	1.74e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—MAOA—schizophrenia	4.96e-06	1.73e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CACNA1C—schizophrenia	4.93e-06	1.72e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—ERBB3—schizophrenia	4.92e-06	1.72e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—MTHFR—schizophrenia	4.92e-06	1.72e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—AKT1—schizophrenia	4.91e-06	1.71e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—YWHAZ—schizophrenia	4.87e-06	1.7e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—YWHAZ—schizophrenia	4.87e-06	1.7e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—PLA2G4A—schizophrenia	4.85e-06	1.69e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—GSTM1—schizophrenia	4.85e-06	1.69e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PIK3C2A—schizophrenia	4.81e-06	1.68e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—EP300—schizophrenia	4.8e-06	1.67e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—ERBB3—schizophrenia	4.76e-06	1.66e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—ERBB3—schizophrenia	4.76e-06	1.66e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—HTR2A—schizophrenia	4.74e-06	1.65e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—ABCB1—schizophrenia	4.71e-06	1.64e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—HTR2A—schizophrenia	4.58e-06	1.6e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—HTR2A—schizophrenia	4.58e-06	1.6e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—APOE—schizophrenia	4.58e-06	1.6e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—GSTM1—schizophrenia	4.57e-06	1.6e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PLA2G4A—schizophrenia	4.57e-06	1.6e-05	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—AKT1—schizophrenia	4.57e-06	1.59e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—APOA1—schizophrenia	4.53e-06	1.58e-05	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—AKT1—schizophrenia	4.47e-06	1.56e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—APOE—schizophrenia	4.4e-06	1.54e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—APOA1—schizophrenia	4.35e-06	1.52e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—IL1B—schizophrenia	4.34e-06	1.52e-05	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—AKT1—schizophrenia	4.33e-06	1.51e-05	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—AKT1—schizophrenia	4.33e-06	1.51e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—SNAP25—schizophrenia	4.31e-06	1.51e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CYP2D6—schizophrenia	4.31e-06	1.51e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—MTHFR—schizophrenia	4.29e-06	1.5e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—APOE—schizophrenia	4.26e-06	1.49e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—APOE—schizophrenia	4.26e-06	1.49e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—APOA1—schizophrenia	4.21e-06	1.47e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—APOA1—schizophrenia	4.21e-06	1.47e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—ESR1—schizophrenia	4.2e-06	1.47e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—IL1B—schizophrenia	4.2e-06	1.47e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—IL1B—schizophrenia	4.2e-06	1.47e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—AKT1—schizophrenia	4.15e-06	1.45e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—ESR1—schizophrenia	4.07e-06	1.42e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—ESR1—schizophrenia	4.07e-06	1.42e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—EP300—schizophrenia	4.05e-06	1.42e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—MTHFR—schizophrenia	4.04e-06	1.41e-05	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—AKT1—schizophrenia	4.03e-06	1.41e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—APOE—schizophrenia	3.99e-06	1.39e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—APOA1—schizophrenia	3.95e-06	1.38e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—TP53—schizophrenia	3.92e-06	1.37e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CYP1A2—schizophrenia	3.9e-06	1.36e-05	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—AKT1—schizophrenia	3.9e-06	1.36e-05	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—AKT1—schizophrenia	3.9e-06	1.36e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—EP300—schizophrenia	3.88e-06	1.36e-05	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—AKT1—schizophrenia	3.87e-06	1.35e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—TH—schizophrenia	3.84e-06	1.34e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—GSK3B—schizophrenia	3.81e-06	1.33e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—APOE—schizophrenia	3.76e-06	1.31e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—EP300—schizophrenia	3.75e-06	1.31e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—EP300—schizophrenia	3.75e-06	1.31e-05	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—AKT1—schizophrenia	3.74e-06	1.31e-05	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—AKT1—schizophrenia	3.74e-06	1.31e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—APOA1—schizophrenia	3.72e-06	1.3e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—GSK3B—schizophrenia	3.69e-06	1.29e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—GSK3B—schizophrenia	3.69e-06	1.29e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—EP300—schizophrenia	3.58e-06	1.25e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—EP300—schizophrenia	3.47e-06	1.21e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—EP300—schizophrenia	3.47e-06	1.21e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—TP53—schizophrenia	3.43e-06	1.2e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—AKT1—schizophrenia	3.31e-06	1.15e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—COMT—schizophrenia	3.27e-06	1.14e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GSTP1—schizophrenia	3.25e-06	1.14e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—MAOA—schizophrenia	3.24e-06	1.13e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—EP300—schizophrenia	3.08e-06	1.08e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—ABCB1—schizophrenia	3.08e-06	1.07e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—EP300—schizophrenia	3e-06	1.05e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GSTM1—schizophrenia	2.99e-06	1.04e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PLA2G4A—schizophrenia	2.99e-06	1.04e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—EP300—schizophrenia	2.9e-06	1.01e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—EP300—schizophrenia	2.9e-06	1.01e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—TP53—schizophrenia	2.9e-06	1.01e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—AKT1—schizophrenia	2.9e-06	1.01e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—MTHFR—schizophrenia	2.64e-06	9.22e-06	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—EP300—schizophrenia	2.61e-06	9.12e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—AKT1—schizophrenia	2.57e-06	8.96e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—EP300—schizophrenia	2.51e-06	8.76e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—AKT1—schizophrenia	2.48e-06	8.67e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—AKT1—schizophrenia	2.48e-06	8.67e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—APOE—schizophrenia	2.46e-06	8.59e-06	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—AKT1—schizophrenia	2.45e-06	8.55e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—APOA1—schizophrenia	2.43e-06	8.49e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—EP300—schizophrenia	2.43e-06	8.48e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—EP300—schizophrenia	2.43e-06	8.48e-06	CbGpPWpGaD
Loperamide—CALM3—Immune System—AKT1—schizophrenia	2.35e-06	8.19e-06	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—EP300—schizophrenia	2.27e-06	7.94e-06	CbGpPWpGaD
Loperamide—CALM1—Immune System—AKT1—schizophrenia	2.27e-06	7.92e-06	CbGpPWpGaD
Loperamide—CALM2—Immune System—AKT1—schizophrenia	2.27e-06	7.92e-06	CbGpPWpGaD
Loperamide—CALM3—Disease—AKT1—schizophrenia	2.17e-06	7.56e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—EP300—schizophrenia	2.14e-06	7.48e-06	CbGpPWpGaD
Loperamide—CALM1—Disease—AKT1—schizophrenia	2.1e-06	7.31e-06	CbGpPWpGaD
Loperamide—CALM2—Disease—AKT1—schizophrenia	2.1e-06	7.31e-06	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—AKT1—schizophrenia	1.86e-06	6.51e-06	CbGpPWpGaD
Loperamide—CALM3—Metabolism—AKT1—schizophrenia	1.81e-06	6.33e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—TP53—schizophrenia	1.8e-06	6.27e-06	CbGpPWpGaD
Loperamide—CALM2—Metabolism—AKT1—schizophrenia	1.75e-06	6.13e-06	CbGpPWpGaD
Loperamide—CALM1—Metabolism—AKT1—schizophrenia	1.75e-06	6.13e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—TP53—schizophrenia	1.74e-06	6.07e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—TP53—schizophrenia	1.74e-06	6.07e-06	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—AKT1—schizophrenia	1.58e-06	5.51e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—AKT1—schizophrenia	1.52e-06	5.29e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—AKT1—schizophrenia	1.47e-06	5.12e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—AKT1—schizophrenia	1.47e-06	5.12e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—EP300—schizophrenia	1.4e-06	4.89e-06	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—AKT1—schizophrenia	1.37e-06	4.8e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—AKT1—schizophrenia	1.3e-06	4.52e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—AKT1—schizophrenia	8.47e-07	2.96e-06	CbGpPWpGaD
